Skip to main content

Statera Biopharma, Inc.

STABDelisted Mar 3, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001318641

Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding Statera Biopharma, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of STAB: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders294−25
Shares2.47M212.9K−2.26M (−91.4%)
Value$197.5K$3.29K−$194.2K (−98.3%)

New holders (0)

Institutions that held Statera Biopharma, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

None.

Sold out (25)

Institutions that held Statera Biopharma, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.